Peter J. Van Veldhuizen, MD

Articles by Peter J. Van Veldhuizen, MD

Dr. Van Veldhuizen Discusses Combination Therapy in RCC

September 19th 2018

Peter J. Van Veldhuizen, MD, hematologist/oncologist, Sarah Cannon Research Institute, discusses combination therapy for the treatment of patients with renal cell carcinoma.

Latest Updated Articles

Dr. Van Veldhuizen Discusses Combination Therapy in RCC
Published: September 19th 2018 | Updated:

Peter J. Van Veldhuizen, MD

Articles by Peter J. Van Veldhuizen, MD

Dr. Van Veldhuizen Discusses Combination Therapy in RCC

Latest Updated Articles

Trending on CGTlive®

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

CGTLive®’s Weekly Rewind – October 17, 2025